India’s Tucatinib 300mg Tablets for Breast Cancer

So, Tucatinib is a drug that’s designed to target the HER2 protein in breast cancer patients with brain tumors that have the HER2-positive thing going on. It’s like a roadblock for HER2, slowing down that signaling process. There are two doses: a 50-milligram one and a 150-milligram one, both in those coated tablet form things.

You’re supposed to take it three hundred milligrams twice a day on the reg, and make sure you’re eating while you do it. Each bottle comes with sixty tabs. It’s super important that you follow the instructions on the dosage, cause that’s how you keep your cancer in check.